Abstract
Urticaria is a cutaneous syndrome characterized by dermal edema (wheal) and erythema (flare) that blanches with pressure. The lesions typically last less than 24 hours and are usually pruritic. In 1983, Christensen and Maibach summarized the theory behind the use of histamine H1 receptor antagonists (antihistamines) in clinical dermatology. These agents remain the mainstay of treatment for urticaria.
This article reviews the medical literature on the effectiveness of antihistamines in urticarial syndromes, including acute, chronic idiopathic and the physical urticarias.
Older antihistamines, such as chlorpheniramine and hydroxyzine, are effective in the treatment of urticarias, but they also have marked sedative and anticholinergic effects. Newer nonsedating antihistamines (second-generation antihistamines) have been developed that have reduced adverse effects because they do not cross the blood-brain barrier; these agents (acrivastine, cetirizine, loratadine, mizolastine, fexofenadine, ebastine, azelastine and epinastine) cause significantly less sedation and psychomotor impairment than their older counterparts.
A review of the literature reveals that there are few studies which document the efficacy of second-generation antihistamines in the treatment of acute urticaria, a biologic entity that usually resolves within 3 weeks. We did not identify controlled studies that suggested superiority of any antihistamine in the treatment of acute urticaria. Loratadine or cetirizine, and possibly mizolastine, appear to be treatments of choice for chronic idiopathic urticaria. For symptomatic dermatographism, the combination of an antihistamine and an H2 antagonist, e.g. chlorpheniramine and cimetidine, appears to be effective. Very few studies have been conducted on the use of antihistamines in the treatment of cold, cholinergic, and pressure urticaria.
Antihistamines are the mainstay of urticarial therapy. This evidence-based review suggests that there are efficacy differences between newer, nonsedating antihistamines and older agents in some forms of the disorder. Clearly, further well-controlled clinical trials in larger numbers of patients are needed to clarify the role of these agents in the treatment of urticaria.
Similar content being viewed by others
References
Vaughn M.P., DeWalt A.C., Diaz J.D. Urticaria associated with systemic disease and psychological factors. In: Charlesworth E.N., editor. Immunology and allergy clinics of North America: Urticaria Vol 15:4 Philadelphia: WB Saunders 1995; 725–743
Matthews K.P. Chronic urticaria. In: Schocket A.L., editor. Clinical management of urticaria and anaphylaxis, New York: Marcel Dekker 1993; 21–68
Stedmans’s Medical Dictionary. 27th ed. Baltimore (MD): Lippincott, Williams & Wilkins, 2000: 1918
Christensen O.B., Maibach H.I. Antihistamines in dermatology. Semin Dermatol 1983; 2: 270–280
Timmerman H. Factors involved in the absence of sedative effects by the secondgeneration antihistamines. Allergy 2000; 55: 5–10
Slater J.W., Zechnich A.D., Haxby D.G. Second-generation antihistamines: a comparative review. Drugs 1999 Jan; 57 (1): 31–47
Ormerod A.D. Urticaria: recognition, causes and treatment. Drugs 1994; 48: 717–730
Phanuphak P., Schocket A.L., Arroyave C.M., et al. Skin histamine in chronic urticaria. J Allergy Clin Immunol 1980; 65: 371–375
Simons F.E., McMillan J.L., Simons K.J. A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects. J Allergy Clin Immunol 1990; 86: 540–547
Grant J.A., Danielson L., Rihoux J.P., et al. A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24h in healthy male subjects. Allergy 1999; 54 (7): 700–707
Bayramgurler D., Bilen N., Apaydyn R., et al. Effects of acrivastine, loratadine, and cetirizine on histamine-induced wheal and flare responses. Clin Exp Dermatol 1999; 24: 407–411
Zuberbier T., Munzberger C., Haustein U., et al. Double-blind, crossover study of high-dose cetirizine in cholinergic urticaria. Dermatology 1996; 193 (4): 324–327
Zuberbier T., Aberer W., Burtin B., et al. Efficacy of cetirizine in cholinergic urticaria. Acta Derm Venereol 1995; 75 (2): 147–149
Fauci A.S., Haynes B.F., Katz P. The spectrum of vasculitis clinical, pathological, immunologic and therapeutic considerations. Ann Int Med 1978; 89: 660–676
Zuberbier T., Ifflander J., Semmler C., et al. Acute urticaria: clinical aspects and therapeutic responsiveness. Acta Derm Venereol (Stockh) 1996; 76: 295–297
Ring K., Behrendt H. H1- and H2-antagonists in allergic and pseudoallergic diseases. Clin Exper Allergy 1990; 20 Suppl. 2: 43–49
Moscati R.M., Moore G.P. Comparison of cimetidine and diphenhydramine in the treatment of acute urticaria. Ann Emerg Med 1990; 19 (1): 12–15
Bleehen S.S., Thomas S.E., Greaves M.W.,et al. Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomised double-blind study. Br J Dermatol 1987; 117 (1): 81–88
Boggs P.B., Ellis C.N., Grossman J., et al. Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria. Ann Allergy 1989; 63: 616–620
Grant J.A., Bernstein D.I., Buckley C.E., et al. Double-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1988; 81: 574–579
Kalis B. Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults. Drugs 1996; 52 Suppl. 1: 30–34
Paul E., Bodeker R.H. Treatment of chronic urticaria with terfenadine and ranitidine: a randomised double-blind study in 45 patients. Eur J Clin Pharmacol 1986; 31: 277–280
Ring J., Brockow K., Ollert M., et al. Antihistamines in urticaria. Clin Exp Allergy 1999; 29 Suppl. 1: 31–37
Rosenzweig P., Caplain H., Chaufour S., et al. Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine, and placebo in healthy volunteers. Br J Clin Pharmacol 1995; 40 (5): 459–465
Dubertret L., Murrieta Aguttes M., Tonet J. Efficacy and safety of mizolastine 10mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study. J Eur Acad Dermatol Venereol 1999; 12 (1): 16–24
Breneman D.L. Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. Ann Pharmacother 1996; 30 (10): 1075–1079
Kalivas J., Breneman D., Tharp M., et al. Urticaria: clinical efficacy of cetirizine in comparison with hydroxyzine and placebo. J Allergy Clin Immunol 1990; 86: 1014–1018
Monroe E.W. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis. Clin Ther 1992; 14 (1): 17–21
Monroe E.W., Berstein D.I., Fox R.W., et al. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria. Arzneimittelforschung 1992; 42 (9): 1119–1121
Greene S.L., Reed C.E., Schroeter A.L. Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. J Am Acad Dermatol 1985; 12 (4): 669–675
Boyle J., Marks P., Gibson J.R. Acrivastine versus terfenadine in the treatment of symptomatic dermatographism — a double-blind, placebo-controlled study. J Int Med Res 1989; 17 Suppl. 2: 9B–13B
Breneman D., Bronsky E.A., Bruce S., et al. Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double-blind, placebo-controlled, comparative trial. J Am Acad Dermatol 1995; 33: 192–198
Paul E., Bodeker R.H. Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomised double-blind study of 40 patients. Ann Allergy 1989; 62 (4): 318–320
Ormerod A.D., Baker R., Watt J., et al. Terfenadine and brompheniramine maleate in urticaria and dermatographism. Dermatologica 1986; 173 (1): 5–8
Cainelli T., Seidenari S., Valsecchi R., et al. Double-blind comparison of astemizole and terfenadine in the treatment of chronic urticaria. Pharmatherapeutica 1986; 4 (10): 679–686
Kietzmann H., Macher E., Rihoux J.P., et al. Comparison of cetirizine and terfenadine in the treatment of chronic idiopathic urticaria. Ann Allergy 1990; 65: 498–500
Abu Shareeah, A.M. Comparative efficacy of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. Int J Dermatol 1992; 31 (5): 355–356
Alomar A., De La Cuadra, Fernandez J. Cetirizine vs astemizole in the treatment of chronic idiopathic urticaria. J Int Med Res 1990; 18 (5): 358–365
Belaich S., Bruttmann G., DeGreef H., et al. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. Ann Allergy 1990; 64: 191–194
Leyh F., Harvey S.G., Gibson J.R., et al. A comparison of acrivastine versus clemastine and placebo in the treatment of patients with chronic idiopathic urticaria. J Int Med Res 1989; 17 Suppl. 2: 22B–24B
Salo O.P., Harvey S.G., Calthrop J.G., et al. A comparison of acrivastine versus hydroxyzine and placebo in the treatment of chronic idiopathic urticaria. J Int Med Res 1989; 17 Suppl. 2: 18B–2 lB
Juhlin L., Gibson J.R., Harvey S.G., et al. Acrivastine versus clemastine in the treatment of chronic idiopathic urticaria. A double-blind, placebo controlled study. Int J Dermatol 1987; 26 (10): 653–654
Neittaanmaki H., Fraki J.E., Gibson J.R. Comparison of the new antihistamine acrivastine (BW 825C) versus cyproheptadine in the treatment of idiopathic cold urticaria. Dermatologica 1988; l77 (2): 98–l03
Neittaanmaki H., Myohanen T., Fraki J.E. Comparison of cinnarizine, cyproheptadine, doxepin, and hydroxyzine in treatment of idiopathic cold urticaria: usefulness of doxepin. J Am Acad Dermatol 1984; 11 (3): 483–489
Kobza Black A., Aboobaker J., Gibson J.R., et al. Acrivastine versus hydroxyzine in the treatment of cholinergic urticaria. A placebo-controlled study. Acta Derm Venereol 1988; 68 (6): 541–544
Michell P., Hawk J.L.M., Shafrir A., et al. Assessing the treatment of solar urticaria. Dermatologica 1980; 160: 198–207
Monfrecola G., Masturzo E., Riccardo A.M., et al. Cetirizine for solar urticaria in the visible spectrum. Dermatology 2000; 200: 334–335
Bilsland D., Ferguson J. A comparison of cetirizine and terfenadine in the management of solar urticaria. Photodermatol Photoimmunol Photomed 1991; 8 (2): 62–64
Dawe R.S., Ferguson J. Prolonged benefit following ultraviolet A phototherapy for solar urticaria. Br J Dermatol 1997; 137 (1): 144–148
Collins P., Ahamat R., Green C., et al. Plasma exchange therapy for solar urticaria. Br J Dermatol 1996; 134: (6) 1093–1097
Breathnach S.M., Allen R., Ward A.M., et al. Symptomatic dermatographism: Natural history, clinical features, laboratory investigations and response to therapy. Clin Exp Dermatol 1983; 8 (5): 463–476
Kaur S., Greaves M.W., Eftekhari N. Factitious urticaria (dermatographism): treatment by cimetidine and chlorpheniramine in a randomised double-blind study. Br J Dermatol 1981; 104: 185–190
Matthews C.N., Boss J.M., Warm R.P., et al. The effect of H1 and H2 histamine antagonists on symptomatic dermatographism. Br J Dermatol 1979; 101: 57–61
Wanderer A.A., Ellis E.F.: Treatment of cold urticaria with cyproheptadine. J Allergy Clin Immunol 1971; 48: 366–371
Wanderer A.A., St. Pierre J.P., Ellis E.F. Primary acquired cold urticaria. Double blind comparative study of treatment with cyproheptadine, chlorpheniramine, and placebo. Arch Dermatol 1977; 113 (10): 1375–1377
Sigler R.W., Evans R., Horakova Z., et al. The role of cyproheptadine in the treatment of cold urticaria. J Allergy Clin Immunol 1980; 65: 309–312
McDonald C.J. Cholinergic and cold urticarias. Postgrad Med 1982; 71: 216
Dubertret L., Leynadier F., Murrieta-Aguttes M. Effect of mizolastine (M) vs placebo in acquired cold induced urticaria (ACIU): the cold stimulation time test (CSTT). Allergy 1996; 51 Suppl. 31: 67
Simons F.E.R. Antihistamines. In: Middleton E., Ellis E.F., Yunginger J.W., et al., editors. Allergy: principle and practice. 5th ed. St Louis (MO): Mosby-Year Book, Inc., 1998: 613
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lee, E.E., Maibach, H.I. Treatment of Urticaria. Am J Clin Dermatol 2, 27–32 (2001). https://doi.org/10.2165/00128071-200102010-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128071-200102010-00005